Skip to main content

Month: April 2026

INTERIM REPORT FOR THE FIRST QUARTER OF 2026 (UNAUDITED)

GROUP CEO’S REVIEW Rait Riim, CEO and Member of the Management Board of Arco Vara AS: “The first quarter of 2026 developed largely as expected for Arco Vara, with the company maintaining its focus on advancing its ongoing development projects. During the quarter, a change also occurred in the company’s management, and as of 1 April, I have assumed the role of Chief Executive Officer of Arco Vara. I have more than 20 years of experience in the real estate sector and joining Arco Vara represents an opportunity for me to contribute to the company’s next phase of development. Arco Vara’s ambition is to be a real estate developer recognized as a benchmark for urban space and living environment quality, sustainability, and long-term value creation. It is important that a developer does not merely construct buildings but creates holistic environments...

Continue reading

OSE Immunotherapeutics Reports Full Year 2025 Unaudited Consolidated Financial Results and 2026 Q1 Cash Position

OSE entered 2026 with a clear 3-year strategic roadmap focused on delivering multiple catalysts for both lusvertikimab and Tedopi®1 €22.7 and €17.0 million cash position as of December 31, 2025, and March 31, 2026, respectively Unchanged cash runway until early Q4 2026 Filing of the 2025 Universal Registration Document is postponed to no later than May 28, 2026NANTES, France, April 30, 2026 – 7:30am CEST – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (the “Company”), today reported its full year 2025 unaudited consolidated financial results, as approved by the Board of Directors on April 29, 2026. Audit procedures by the Company’s statutory auditors on the Company’s 2025 consolidated financial statements are still ongoing. Full Year 2025 Consolidated Financial Results (IFRS, unaudited)     In million...

Continue reading

Nicox Provides Full Year 2025 Financial Results and Corporate Update

Press ReleaseNicox Provides Full Year 2025 Financial Results and Corporate UpdateRevenue of €16.8 million (€7.9 million in 2024) Net loss significantly reduced to €2.4 million (€22.4 million in 2024) NCX 470 U.S. New Drug Application (NDA) submission on track for summer 2026, with associated milestone payment Regulatory milestones anticipated to extend cash runway beyond 2027April 30, 2026 – release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, today announced its financial results for the full year of 2025, as approved by the Board of Directors on 29 April 2026, and provided an update on key future milestones. “2025 marked a pivotal turning point for Nicox,” said Gavin Spencer, Chief Executive Officer of Nicox. “We have significantly...

Continue reading

Strong Q1 2026 financial results, on track to achieve PowerUP 2026 targets

NET INCOME GROUP SHARE OF EUR 266 MILLION, UP 21.2% VS. Q1 2025  RETURN ON TANGIBLE EQUITY (ROTE) AT 13.9% VS. 11.0% IN Q1 2025EPS1 AT EUR 0.31 UP 29% VS. Q1 2025 Q1 2026 RESULTS2 Leasing and Services margins at EUR 757 million, up 6.9% vs. Q1 2025 Underlying margins3 at 587 bps of average earning assets vs. 562 bps in Q1 2025 Net Used Car Sales result4 at EUR 59 million down 46.9% vs. Q1 2025 Gross UCS result per unit5 at EUR 470, in line with 2026 guidance Synergies6 at EUR 110 million, up from EUR 61 million in Q1 2025, on track to achieve PowerUP 2026 target of EUR 440 million for full year 2026 Cost to income ratio7 at 54.0%, down 4 percentage points vs. 58.0% in Q1 2025 Earning assets8 at EUR 52.5 billion, -1.8% vs. March 2025 CET1 ratio at 13.9% as at end March 2026 “Ayvens delivered once again a strong set of financial results...

Continue reading

Inbank unaudited financial results for Q1 2026

Inbank started 2026 with strong sales growth and stable underlying performance, while profitability development was more moderate. In Q1 2026 Inbank earned a consolidated net profit of €4 million, decreasing 11% year-on-year. The return on equity (ROE) in Q1 was 9.4%.In Q1 2026, Inbank’s total net income amounted to €21.9 million, increasing 5% year-on-year. Operating expenses increased to €12.1 million, reflecting higher continued investments in technology and marketing spend, while remaining stable compared to the previous quarters. Originated volume reached €206 million, increasing 24% year-on-year and marking a record quarterly result. Regionally growth was led by Central and Eastern Europe, where originated volume increased by 33%, while the Baltics also delivered solid growth of 18%. Sales growth was broad-based across most product...

Continue reading

Solid financial performance in the first quarter of 2026 driven by good customer activity, lending growth and strong credit quality Net profit of DKK 5.7 billion

Press releaseDanske BankBernstorffsgade 40DK-1577 København VTel. + 45 45 14 14 00 30 April 2026 Page 1 of 3Solid financial performance in the first quarter of 2026 driven by good customer activity, lending growth and strong credit qualityNet profit of DKK 5.7 billion Carsten Egeriis, Chief Executive Officer, comments on the financial results: “In the first quarter of 2026, we again delivered solid financial results. They were driven by growth in both lending and deposits and a solid development in core income lines as well as cost management in line with plans. Market volatility impacted net trading income and the insurance service result, although some of the effect is temporary. In addition, credit quality remained strong. The financial performance was underpinned by good customer activity in several segments of the business,...

Continue reading

Company announcement for the first quarter of 2026

Company announcement number 35/2026                                                                                                                                30 April 2026 Company announcement for the first quarter of 2026 Kamilla Hammerich Skytte, CEO, comments on the first quarter of 2026: “Realkredit Danmark has started 2026 with growth in nominal lending and a high level of activity that reflects continued solid momentum in the Danish housing market supported by rising house prices and our customers’ robust economic condition. In the commercial property market Realkredit Danmark saw a high level of activity, characterised in particular by interest from both Danish and international investors in investing in residential rental properties. Corporate lending activity was also high in the first quarter of 2026, with increasing demand...

Continue reading

AS Ekspress Grupp: Consolidated unaudited interim report for Q1 of 2026

In the 1st quarter of 2026, the revenue of Ekspress Grupp decreased by 1% year-over-year and totalled EUR 16.8 million. At the same time, EBITDA increased by EUR 0.6 million. Digital revenue remained at last year’s level and accounted for 86% of the Group’s total revenue. The revenue of AS Ekspress Grupp for the 1st quarter of 2026 decreased by EUR 0.2 million (-1%) year-over-year, totalling EUR 16.8 million. The Q1 revenue comparison base is affected by transactions that occurred in December 2025 – the sales of the Lithuanian news portal Lrytas UAB and the acquisition of the traffic training platform Liikluslab Baltic OÜ. Excluding these transactions, the revenue for the 1st quarter increased by EUR 0.1 million (+1%). The continued growth of digital subscription revenue and revenue from ticket sales platforms contributed positively...

Continue reading

Q1 2026 revenues

Media relations:Victoire GruxTel.: +33 6 04 52 16 55victoire.grux@capgemini.com Investor relations:Vincent BiraudTel.: +33 1 47 54 50 87vincent.biraud@capgemini.com Q1 2026 revenuesQ1 2026 revenues of €5,943 million, up + 7.0% at current exchange rates and +11.0% at constant exchange rates* Bookings of €6,054 million, up +6.2% at constant exchange ratesParis, April 30, 2026 – The Capgemini Group reported Q1 2026 revenues of €5,943 million, up +7.0% at current exchange rates and +11.0% at constant exchange rates*. Aiman Ezzat, Chief Executive Officer of the Capgemini Group, said: “This quarter’s performance validates our cloud and AI strategy, delivering strong underlying growth, in line with Q4 2025 and outperforming most peers in the market. We secured major transformational deals and long-term commitments, including the five–year...

Continue reading

Arcadis Q1 2026 Trading Update: Strong order intake and strategic progress

PRESS RELEASE | Arcadis First Quarter 2026 Trading UpdateStrong order intake and strategic progressStrong Order Intake of €1.1B with 1.19x book-to-bill, backlog of €3.8B with 4.6% organic growth1) ytd Net Revenues of €933 million, with 0.8% organic growth yoy Operating EBITA Margin2) at 11.0% (Q1‘25: 10.9%) supported by the cost-out and rightsizing actions Capital Markets Day on September 29, 2026 to set mid-term strategy for 2027-2029Amsterdam, 30 April 2026 – Arcadis, the world’s leading company delivering data-driven sustainable design, engineering, and consultancy solutions for natural and built assets, reports first quarter results with strong order intake of €1.1 billion, Net Revenues of €933 million representing 0.8% year-on-year growth, while Operating EBITA margin was 11.0% (Q1’25: 10.9%). Heather Polinsky, CEO Nominee...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.